Innovation and Technologies 09 December 2021 Fareva and ApiJect sign a licensing agreement to create a France-based 500M unit annual capacity for single-dose prefilled vaccine injections Read more
Innovation and Technologies 10 May 2021 Fareva increases manufacturing capacity for highly potent drug product manufacturing Read more
Corporate 18 January 2021 MSD closes transaction to sell its Mirabel production site to FAREVA pharmaceutical group Read more
Corporate 09 December 2020 CureVac and Fareva sign agreement for fill & finish manufacturing of CureVac’s COVID-19 vaccine candidate, CVNCOV Read more
Corporate 30 November 2020 Fareva strengthens its position in sterile development and manufacturing Read more
Corporate 28 October 2020 Fareva is one of the world leaders in pharmaceutical subcontracting in the field of sterile products. Read more